Ex-US Countries definition
Examples of Ex-US Countries in a sentence
During the Sanofi Option Period, Sanofi shall have an exclusive option (the “Option”) to participate in the Development and Commercialization of the Licensed Products for the KaloBios Field as described in this Section 4.9 in either (i) the Ex-US Countries as described in Section 4.9(b); or (ii) the Ex-US Countries and Fifty Percent (50%) of the US Territory as described in Section 4.9(c).
In addition, in the event that Virobay proposes to grant a security interest to a Third Party licensee in any of the Virobay Patents in any country of the world other than the Key Ex-US Countries, then Virobay shall not grant such security interest without also granting ▇▇▇ the same priority in such Virobay Patents as the security interest proposed to be granted to such Third Party licensee.
Upon exercise of the Option pursuant to this Section 4.9(c) for the Ex-US Countries plus [***] in the U.S. Territory, Sanofi shall pay to KaloBios an amount equal to [***].
Upon exercise of the Option pursuant to this Section 4.9(c), Sanofi will be responsible for the Development of Licensed Products in the KaloBios Field for the Ex-US Countries and the Parties will [***] responsibility for conducting the Development of Licensed Products in the KaloBios Field for the U.S. Territory.
Following the exercise of the Option pursuant to this Section 4.9(c), Sanofi shall pay to KaloBios a royalty on Net Sales of Licensed Products in the Ex-US Countries in the KaloBios Field equal to Eighteen Percent (18%) of such Net Sales in accordance with the terms of Article 8 (other than Section 8.3(a) and in lieu of the amounts described in Section 8.6 with respect to the Ex-US Countries).
Upon exercise of the Option pursuant to this Section 4.9(b) for the Ex-US Countries, Sanofi shall pay to KaloBios an amount equal to [***].
Following the exercise of the Option pursuant to this Section 4.9(c), Sanofi shall pay to KaloBios a royalty on Net Sales of Licensed Products in the Ex-US Countries in the KaloBios Field equal to [***] of such Net Sales in accordance with the terms of Article 8 (other than Section 8.3(a) and in lieu of the amounts described in Section 8.6 with respect to the Ex-US Countries).
Monogram shall perform the Commercial Assay with respect to any Samples originating from Customers in Ex-US Countries and received at the Monogram Facility.
Upon exercise of the Option pursuant to this Section 4.9(b) for the Ex-US Countries, Sanofi shall pay to KaloBios an amount equal to One Hundred Percent (100%) of the KaloBios Development Costs incurred by KaloBios in respect of Development of Licensed Product in the KaloBios Field from and after the Effective Date through the Option Exercise Date.
The JSC may, following review, either approve or reject elements of the Infrastructure Plans for each of the Ex-US Countries.